Accelerate research, empower industry



Wu W, Pu Y, Gao S, et al. Bacterial Metabolism-Initiated Nanocatalytic Tumor Immunotherapy[J]. Nano-Micro Letters, 2022, 14(1): 1-21. IF: 23.65


Bu, J., Zhang, Y., Wu, S. et al. KK-LC-1 as a therapeutic target to eliminate ALDH+ stem cells in triple negative breast cancer. Nat Commun 14, 2602 (2023). IF: 17.694


Li W, Ali T, Zheng C, et al. Fluoxetine regulates eEF2 activity (phosphorylation) via HDAC1 inhibitory mechanism in an LPS-induced mouse model of depression[J]. Journal of neuroinflammation, 2021, 18(1): 1-19. IF: 8.322


Li W, Ali T, Zheng C, et al. Anti-depressive-like behaviors of APN KO mice involve Trkb/BDNF signaling related neuroinflammatory changes[J]. Molecular Psychiatry, 2022, 27(2): 1047-1058. IF: 15.992


Xiao P, Chen J, Zeng Q, et al. UNC5B Overexpression Alleviates Peripheral Neuropathic Pain by Stimulating Netrin-1-Dependent Autophagic Flux in Schwann Cells[J]. Molecular Neurobiology, 2022: 1-15. IF: 5.59


Kang J, Abudurufu M, Zhang S, et al. lncRNA VIM-AS1 acts as a prognostic biomarker and promotes apoptosis in lung adenocarcinoma[J]. Journal of Cancer, 2023, 14(8): 1417. IF: 3.9


Ma B, Ju A, Zhang S, et al. Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease[J]. Signal Transduction and Targeted Therapy, 2023, 8(1): 229. IF: 38.12


Li T, Wang H, Jiang Y, et al. LITTIP/Lgr6/HnRNPK complex regulates cementogenesis via Wnt signaling[J]. International Journal of Oral Science, 2023, 15(1): 33. IF: 2.7


Xu B, Sui Q, Hu H, et al. SAMHD1 Attenuates Acute Inflammation by Maintaining Mitochondrial Function in Macrophages via Interaction with VDAC1[J]. International Journal of Molecular Sciences, 2023, 24(9): 7888. IF: 5.6


Who Cited Us
Accelerate research, empower industry
Contact Us
Title
Name
*
Project Description
*
Country/Region
*
How would you like us to contact you?
*
E-mail
*
Institution
Phone
Verification code
 Change Image
*
Submit
Tell Us Your Demand
Contact Us


Address: 56 Sugar Creek Blvd Suite 375, Sugar Land, TX 77478

Email: info@hysigen.com

Telephone: 628-777-8169 (US)

Accelerate research, empower industry